Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Real-time Estimate Tradegate
Other stock markets
 09:20:05 2024-05-24 am EDT 		5-day change 1st Jan Change
90.9 EUR +0.94% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. +5.04% +50.66%
May. 08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
LABORATORIOS FARMACEUTICOS ROVI, S.A.
Other Pharmaceuticals
+0.72%+5.04%+50.66%+108.79%+373.63% 5.05B
Bullish
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Charts Laboratorios Farmaceuticos Rovi, S.A.
  5. Comparison Chart